Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Price:
619.25
INR
17.09%
Market Closed
Market Cap:
₹12.4B
Relative Value
The Relative Value of one
LINCOLN
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 619.25 INR,
Lincoln Pharmaceuticals Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LINCOLN Relative Value
HIDDEN
Multiples Across Competitors
LINCOLN Competitors Multiples
Lincoln Pharmaceuticals Ltd Competitors
Lincoln Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
|
12.6B INR | 2 | 14.4 | 10.2 | 11.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
960.1B USD | 14.7 | 46.5 | 31.4 | 33.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579.4B USD | 6.2 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284.8B CHF | 4.6 | 30.3 | 12.8 | 14.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.1B GBP | 5.5 | 34.2 | 16.2 | 23.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.3B CHF | 5.4 | 21.6 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10.1 | 11.8 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158B USD | 2.5 | 20.3 | 7.5 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.2B USD | 2.5 | 17.3 | 6.8 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
